Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 36.27B | 32.68B | 31.10B | 27.81B | 25.77B |
Gross Profit | 8.12B | 7.15B | 6.80B | 6.67B | 6.38B |
EBITDA | 4.47B | 3.57B | 2.96B | 2.58B | 1.92B |
Net Income | 2.39B | 1.78B | 1.40B | 1.05B | 747.76M |
Balance Sheet | |||||
Total Assets | 22.49B | 20.06B | 17.52B | 16.24B | 16.80B |
Cash, Cash Equivalents and Short-Term Investments | 5.68B | 5.92B | 5.07B | 4.91B | 5.02B |
Total Debt | 1.95B | 2.55B | 2.13B | 2.72B | 3.45B |
Total Liabilities | 8.87B | 8.05B | 7.09B | 6.79B | 7.39B |
Stockholders Equity | 13.55B | 11.95B | 10.38B | 9.40B | 9.37B |
Cash Flow | |||||
Free Cash Flow | 3.39B | 1.21B | 1.51B | 1.68B | -796.40M |
Operating Cash Flow | 3.56B | 1.42B | 1.65B | 1.84B | -607.39M |
Investing Cash Flow | -2.28B | -233.18M | -360.39M | -9.40M | -612.07M |
Financing Cash Flow | -1.51B | -432.38M | -1.28B | -1.89B | 1.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥25.99B | 10.95 | 1.20% | 9.56% | 7.39% | ||
77 Outperform | ¥63.61B | 16.80 | 2.31% | 11.92% | 7.75% | ||
76 Outperform | ¥37.77B | 15.57 | 2.61% | 12.33% | 48.96% | ||
73 Outperform | €36.10B | 10.80 | 10.08% | 4.68% | -3.66% | 31.12% | |
68 Neutral | ¥33.10B | 16.43 | 3.41% | 2.06% | 83.15% | ||
68 Neutral | ¥242.18B | 15.62 | 6.62% | 2.44% | 9.08% | 2.46% | |
67 Neutral | ¥24.90B | 32.67 | 1.69% | 5.38% | -8.86% |